White Paper

iPulser White Paper – 02.13.19

Introduction to iPulser

iPulser is a personalized pulsed electro-magnetic therapy device.

Moran Even, Dip CM, PEMT

The device emits specific pulsed electromagnetic frequencies, governed by a patient-accessible app that outputs therapies defined by clinician prescription.

This paper includes:

  1. The mechanism of action of extremely low electromagnetic fields
  2. The technology’s demonstrated effectiveness in published studies and experimental use.
  3. Its nominal mode of use
  4. Status of development of the iPulser system

iPulser mechanism of action

The use of pulsed electromagnetic field therapy (PEMFT) via prescriptive frequencies is specifically targeted at the cell membrane1 . This targeting has demonstrated that specific frequencies influence the calcium-potassium gates on the cell membrane, which regulate cell function. It also shows that the application of specific frequencies is far more clinically instrumental than intensity.

A review article in the American Journal of Health Research (2003),2 summarizes PEMF therapy’s mechanism of action on:

  1. ATP production
  2. Decreased pain, via reduced inflammation
  3. Healing, via tissue repair

Demonstrated effectiveness in published studies

The above paper in turn references additional papers within multiple fields of medicine in which PEMF therapy can be applied. These papers support the observation that specific frequencies affect specific functions in the human body.

These papers also indicate that chronic pain patients can achieve relief to many symptoms, including pain. This includes patients who suffers from fibromyalgia3, musculoskeletal pain4, osteoarthritis5, lower back pain in menopausal women6, cervical osteoarthritis7, migraines8.

Demonstrated effectiveness in experimental use of the iPulser device

The iPulser system has been used in isolation with targeted observation on 40 patients. In addition, it has been used on hundreds of patients in an integrative way, in combination with acupuncture and herbs. Each isolated patient was treated and observed for four weeks. These patients ranged in age from seven- years to eighty-years old and ranged widely in general health and in identified conditions treated.

The author’s clinical experience on these patients indicates that the iPulser has had an effect on specific ganglions of the ANS, as determined via bio-feedback device and from clinical observation, manifested in:

  • §  Pain relief
  • §  Enhanced injury recovery, via its influence on ANS ganglions, specifically the Sacral plexus, hypogastric ganglions, stellar plexus and Vagus nervei
  • §  Enhancement of reported sleep
  • §  Increase in reported vitality In addition, the author has successfully applied the iPulser device to treat patients with chronic states described in the papers below, as well as on IBS (Irritable bladder syndrome), MS (multiple sclerosis), Fatigue (including post chemotherapy), post shingles pain and pelvic floor pain. Nominal mode of use The overall approach to use of the iPulser device is locational, targeting four main anatomical regions that affect the body’s ANS: Neck – Stellar Plexus and Vagus nerve – usually used for upper body and extremities complaints Lower back (on the sacral bone) – Sacral Plexus and Hypo-Gastric Ganglion, for lower body and extremities complaints Upper Tibia (st-36 point in Chinese medicine) – for upper body and extremities complaints Lower Tibia (just above the joint) – for lower body and extremities complaints
    The tibia locations are known to be mirror-image trigger points for the upper and lower spine. The treatment time is about 20-30 min, once or twice a day, which the patient can administer daily at home. Specific treatments are defined by the iPulser software, comprised of a clinician-accessed dashboard in an online portal, and a patient app. The treatments are selected and applied to the patient by the clinicians via the online portal and its clinician dashboard. The patient then accesses the prescription(s) and initiates the treatments via the iPulser App, running on the patient’s mobile device.

i Therapy experience by Dr. Dennis Greenlee, D.C., L.Ac., bears the same indication.

Status

The iPulser system, comprised of device, clinician’s portal and patient app, has been in experimental use for over one year. A market-introductory system is currently under development. The device has been successfully prototyped and is now being produced in a 100-unit Beta prototype run. These prototypes will form the basis for an informal Beta field study, to assess and document effectiveness in treatment of specific conditions, as well as clinician and patient input on its interaction. In conjunction, a cloud-enabled Beta clinician’s portal and patient app will be implemented and assessed.

Moran Even, Dip CM, PEMT, is a Chinese medicine and electromagnetic therapy practitioner, applying a unique approach to therapy in his private practice and at the unit for integrated medicine for oncology patients at the Sourasky Medical Center in Tel Aviv. Moran is also engaged in the development of paramedical technologies that utilize electromagnetic frequencies.

1 Annals of Biomedical Engineering (2009), Electromagnetic Field at 15.95–16 Hz is Cardio Protective Following Acute Myocardial Infarction, Sharon Brazelai et al.

2 American Journal of Health Research (2003), A review of pulsed electromagnetic field (PEMF) mechanisms at a cellular level: a rationale for clinical use, Brett Wade

3 Pain research magazine (2006), exposure to specific low frequency magnetic field, a double blind placebo controlled study of effects on pain rating in rheumatoid arthritis and fibromyalgia patients, Shupak et al.

4 The Journal of the Canadian Pain Society (2007), A randomized, double-blind, placebo-controlled clinical trial, Thomas, Alex W et al.

5 Rheumatology (2012), Effects of pulsed electromagnetic field on knee osteoarthritis: a systematic review, Seo Ryang We et al.

6 Journal of American Science (2011), Pulsed Electromagnetic Field versus Microcurrent on Treatment of Mechanical Low Back Pain in Post-Menopausal Women, Naveen A at al.

7 Rheumatology Int (2006), The effect of pulsed electromagnetic fields in the treatment of cervical osteoarthritis: a randomized, double-blind, sham-controlled trial, Serap Tomruk Sutbeyaz et al.

8 Headache (1999), Treatment of migraine with pulsing electromagnetic fields: a double-blind, placebo-controlled study. Sherman et al